Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer

Area of Science:

• Oncology
• Gastroenterology

Background:

• Colorectal cancer (CRC) is a leading cause of cancer death, with metastasis occurring in nearly half of patients.
• Oligometastatic CRC, defined by limited metastatic spread, presents a distinct clinical state with potentially better outcomes.
• Precise definition and management strategies are crucial due to varied clinical presentations.

Purpose of the Study:

• To review the concept and definition of oligometastatic colorectal cancer (CRC).
• To examine multidisciplinary treatment approaches for oligometastatic CRC.
• To highlight the need for further research to optimize treatment strategies.

Main Methods:

• Literature review focusing on oligometastatic colorectal cancer (CRC).
• Analysis of multidisciplinary treatment modalities including local therapies and systemic therapy.
• Examination of prognostic factors and treatment outcomes.

Main Results:

• Oligometastatic CRC, including oligo-recurrence, offers a more favorable prognosis.
• Complete eradication of metastases is the primary treatment goal.
• Local treatments (surgery, ablation, radiotherapy) are key, with perioperative systemic therapy improving progression-free survival.

Conclusions:

• Surgical resection is the standard of care for oligometastatic CRC.
• Less invasive local treatments are effective alternatives for select patients.
• Further prospective trials are essential to refine definitions and optimize treatment protocols for oligometastatic CRC.